Literature DB >> 24238488

Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.

Murat Saritemur1, Mehmet Turkeli2, Kamuran Kalkan3, İbrahim Halil Tanboga3, Enbiya Aksakal3.   

Abstract

OBJECTIVES: To investigate the predictive role of serum uric acid (SUA) levels measured in the emergency department (ED) to monitor contrast-induced nephropathy (CIN) and correlation with severity of nephropathy in patients undergoing primary percutaneous coronary intervention (PCI).
METHOD: The patients who were admitted to our ED and underwent primary PCI were enrolled retrospectively. Their baseline characteristics including SUA and creatinine levels in the ED and their creatinine levels 48 hours after PCI were noted. Nephropathy was graded as follows: grade 0, ΔCr ≤25% and ≤0.5 mg/dL; grade 1, ΔCr >25% but ≤0.5 mg/dL; and grade 2, ΔCr >0.5 mg/dL. A multiple logistic regression analysis was used to define the independent predictors of CIN.
RESULTS: Of a total of 744 patients, CIN was observed in 12.5% (n = 93). Serum uric acid levels were significantly higher in the CIN (+) group compared with the CIN (-) group (6.09 ± 2.01 mg/dL vs 4.89 ± 1.32 mg/dL, respectively; P < .001). Patients with grade 0 CIN had significantly lower SUA levels than did those with grades 1 and 2 (4.89 ± 1.32 mg/dL vs 5.88 ± 1.99 and 6.41 ± 2.02 mg/dL, respectively; P < .001), but there was no significant difference between grade 1 and grade 2 CIN cases in terms of SUA levels (5.88 ± 1.99 mg/dL vs 6.41 ± 2.02 mg/dL, P = .10). The cutoff value for SUA was 5.05 mg/dL for the prediction of CIN (area under the curve, 0.685; P < .001; sensitivity, 66%; specificity, 60%) in the population.
CONCLUSIONS: The SUA level is a simple independent early predictor of CIN in patients who underwent primary PCI, and early detection may help prevent the progression of CIN.
© 2013.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24238488     DOI: 10.1016/j.ajem.2013.10.011

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

Review 1.  Renal-related adverse effects of intravenous contrast media in computed tomography.

Authors:  Kheng Song Leow; Yi Wei Wu; Cher Heng Tan
Journal:  Singapore Med J       Date:  2015-04       Impact factor: 1.858

Review 2.  Nonpharmacological strategies to prevent contrast-induced acute kidney injury.

Authors:  Paweena Susantitaphong; Somchai Eiam-Ong
Journal:  Biomed Res Int       Date:  2014-03-26       Impact factor: 3.411

3.  Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency.

Authors:  Ziliang Ye; Haili Lu; Qiang Su; Xinhua Xian; Lang Li
Journal:  Oncotarget       Date:  2017-07-24

4.  The relationship between hyperuricemia and contrast-induced acute kidney injury undergoing primary percutaneous coronary intervention: secondary analysis protocol for the ATTEMPT RESCIND-1 study.

Authors:  Wei Guo; Feier Song; Shiqun Chen; Li Zhang; Guoli Sun; Jin Liu; Jiyan Chen; Yong Liu; Ning Tan
Journal:  Trials       Date:  2020-06-24       Impact factor: 2.279

5.  Is there any association between contrast-induced nephropathy and serum uric acid levels?

Authors:  Fardin Mirbolouk; Samira Arami; Mahboobe Gholipour; Yasaman Khalili; Seyedeh Shiva Modallalkar; Mona Naghshbandi
Journal:  J Cardiovasc Thorac Res       Date:  2021-02-20

6.  Uric acid and contrast-induced nephropathy: an updated review and meta-regression analysis.

Authors:  Francesco Pelliccia; Vincenzo Pasceri; Giuseppe Patti; Giuseppe Marazzi; Giuseppe De Luca; Gaetano Tanzilli; Nicola Viceconte; Giulio Speciale; Enrico Mangieri; Carlo Gaudio
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-12-11       Impact factor: 1.426

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.